Qiming Venture Partners
Qiming Venture Partners is a leading global venture capital firm managing multiple US Dollar and RMB funds with over $9.5 billion in capital raised. They focus on early and growth-stage investments in Technology & Consumer and Healthcare sectors, boasting a portfolio of influential companies.
📥 Buy Full VC Dataset
Offices: Shanghai (China), Beijing (China), Hong Kong (Hong Kong), Suzhou (China), Singapore (Singapore)
Investment Stages: Series A, Series B
Markets: Technology and Consumer (T&C), Healthcare, Information technology, New consumer business patterns, Mobile internet, Social networking, Entertainment, Artificial intelligence, Robotics, Semiconductors, Enterprise software, Blockchain, Manufacturing, Diagnostics, R&D, Medical equipment, Medical services, Digital Healthcare
Founded Year: 2006
Investor Type: Venture Capital
Portfolio Companies: Xiaomi, Meituan, Bilibili, Zhihu, Roborock, UBTech, WeRide, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, Yuanxin Technology, Caidya, Belief BioMed, HyperStrong, WeDoctor, Dianping, Tigermed, ZaiLab, UBTech, Berry Genomics, CooTek, Sinocelltech, Tongdun, Tellgen, Unisound, Cansinotech, Mafengwo, Meitu, Bilibili, Roborock, Miaoshou Doctor, Transwarp, Tujia
Website: https://www.qimingvc.com/
Team Page: https://www.qimingvc.com/en/team
Portfolio Link: https://www.qimingvc.com/en/portfolio
LinkedIn: https://www.linkedin.com/company/qiming-venture-partners
Twitter: https://twitter.com/QimingVC
Crunchbase: https://www.crunchbase.com/organization/qiming-venture-partners
Comments
No comments yet. Be the first to comment!